We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$687M
AUM Growth
+$60.4M
Cap. Flow
+$6.5M
Cap. Flow %
0.95%
Top 10 Hldgs %
58.27%
Holding
489
New
48
Increased
120
Reduced
55
Closed
29
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGG icon
201
iShares Core US Aggregate Bond ETF
AGG
$138B
$33K ﹤0.01%
334
BURL icon
202
Burlington
BURL
$23.2B
$33K ﹤0.01%
143
KHC icon
203
Kraft Heinz
KHC
$30.5B
$33K ﹤0.01%
1,286
+20
+2% +$555
VSGX icon
204
Vanguard ESG International Stock ETF
VSGX
$6.69B
$33K ﹤0.01%
499
-10
-2% -$617
UL icon
205
Unilever
UL
$139B
$32K ﹤0.01%
471
KMB icon
206
Kimberly-Clark
KMB
$37.4B
$31K ﹤0.01%
237
+2
+0.9% +$271
DHT icon
207
DHT Holdings
DHT
$2.88B
$30K ﹤0.01%
+2,735
New +$30.1K
NVO
208
Novo Nordisk
NVO
$197B
$30K ﹤0.01%
433
CHD icon
209
Church & Dwight Co
CHD
$24.6B
$29K ﹤0.01%
300
MCHP icon
210
Microchip Technology
MCHP
$42.2B
$29K ﹤0.01%
408
TMO icon
211
Thermo Fisher Scientific
TMO
$214B
$29K ﹤0.01%
71
APD icon
212
Air Products & Chemicals
APD
$65.7B
$28K ﹤0.01%
100
-9
-8% -$2.46K
CME icon
213
CME Group
CME
$95.2B
$28K ﹤0.01%
100
-10
-9% -$2.72K
COF icon
214
Capital One
COF
$136B
$28K ﹤0.01%
+131
New +$24.4K
D icon
215
Dominion Energy
D
$60B
$28K ﹤0.01%
500
MAR icon
216
Marriott International
MAR
$94.2B
$28K ﹤0.01%
104
VGT icon
217
Vanguard Information Technology ETF
VGT
$147B
$28K ﹤0.01%
336
NOC icon
218
Northrop Grumman
NOC
$79.2B
$27K ﹤0.01%
54
VTV icon
219
Vanguard Morningstar Value ETF
VTV
$191B
$27K ﹤0.01%
150
DIS icon
220
Walt Disney
DIS
$177B
$26K ﹤0.01%
209
-550
-72% -$57.1K
GSK icon
221
GSK
GSK
$103B
$26K ﹤0.01%
685
APO icon
222
Apollo Global Management
APO
$74.7B
$25K ﹤0.01%
176
WMB icon
223
Williams Companies
WMB
$87.8B
$25K ﹤0.01%
400
AMD icon
224
Advanced Micro Devices
AMD
$786B
$24K ﹤0.01%
172
+6
+4% +$653
GILD icon
225
Gilead Sciences
GILD
$164B
$24K ﹤0.01%
218

Similar funds

Roble Belko & Company's Q2 2025 Portfolio in Review

As of Q2 2025, Roble Belko & Company held 489 positions worth $687M, up 9.6% from $627M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Roble Belko & Company's Q2 2025 filing shows 48 new, 120 increased, 55 reduced and 29 closed positions. Its largest new stake was Lockheed Martin: 1,233 shares worth $571K. The largest sale was Vanguard International High Dividend Yield ETF, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 1.6% of assets, up from 1.6% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q2 2025 buy was Lockheed Martin: 1,233 shares worth $571K.
  • Roble Belko & Company added most to State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q2 2025, an estimated $14.4M increase.
  • Roble Belko & Company's biggest Q2 2025 reduction was Vanguard International High Dividend Yield ETF, cutting an estimated $11.6M.
  • Roble Belko & Company fully exited Vanguard Russell 1000 ETF in Q2 2025, selling an estimated $470K.
  • Roble Belko & Company's ten largest holdings make up 58% of its $687M portfolio in Q2 2025.
  • Roble Belko & Company opened 48 new positions and closed 29 in Q2 2025.
  • Roble Belko & Company's portfolio value rose 9.6% quarter-over-quarter to $687M.

Based on Roble Belko & Company's 13F filing for Q2 2025, filed 4 Aug 2025.